|
|
|
|
Equitape
Contra-indications, warnings, etc
Do not use in
horses producing milk for human consumption.
Withdrawal period
for edible tissue: zero days
The safety of
EQUITAPE has not been studied following administration to mares
during gestation and lactation, and as such should only be used in
mares during pregnancy and lactation after assessment of the
benefit/risk balance by your veterinary surgeon.
Wash hands
thoroughly after treating animals.
Do not eat, drink
or smoke during application.
Any spillage of
the product onto human skin should be removed by washing with soap
and water.
Read entire
package insert before use.
For animal
treatment only.
Keep out of reach
of children.
Environmental Safety
In order to limit
pasture excretion of the product and its metabolites, horses should
remain stabled for 2 days after treatment. Unused product or waste
material must be disposed of in accordance with national waste
disposal requirements
Presentation
A white paste
containing: 90.0mg/g praziquantel Ph.Eur as active substance and
0.2mg/g propyl parahydroxybenzoate (E216) and 1.4mg/g methyl
parahydroxybenzoate (E218) as preservatives.
Uses
Praziquantel
is a pyrazino-isoquinoline derivative. For the single dose
treatment of infections with cestodes (tapeworms) of the species
Anoplocephala perfoliata sensitive to
praziquantel.
Dosage
and administration
For
oral administration. One 6.67g syringe contains
sufficient paste to treat one 600kg horse at the
recommended dose rate (1mg praziquantel per kg
bodyweight). Each graduation on the calibrated syringe
delivers sufficient paste to treat 50kg bodyweight. Use
of a scale or weigh tape is recommended to ensure
accurate dosing.
|
Pharmaceutical precautions
No special
precautions for storage.
Further information
As
tapeworm infection is unlikely to occur in horses
before two months of age, treatment of foals below
this age is not considered necessary.
In
horses with severe infections, treatment may result
in mild, transient colic and loose faeces due to the
destruction of the tapeworms.
Parasite resistance to a particular class of
anthelmintic may develop following frequent,
repeated use of an anthelmintic of that class.
In
the absence of compatibility studies this veterinary
product must not be mixed with other medicinal
products.
Marketing Authorisation Holders:
Bayer plc, Animal Health. Division, Bayer House,
Strawberry Hill, Newbury, Berkshire RG14 1JA
Distributed in UK by: Fort
Dodge Animal Health Ltd, Flanders Road, Southampton,
SO30 4QH
|
|
|
|
